Clinical Trial Update: Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tacrolimus for superficial Kaposiform Hemangioendothelioma and Tufted Angioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma
• Tufted Angioma

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: West China Hospital | Conditions: Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma | Phase 2 | Status: RECRUITING